护理点 (POC) 数据管理软件市场 - 增长、趋势、COVID-19 影响和预测（2022-2027 年）

在预测期内，床旁 (POC) 数据管理软件市场预计将以 12.3% 的复合年增长率增长。

护理点技术使医院和诊所能够将更多时间用于技术，以加快患者通过护理的流程、减少等待时间并简化医生和护士的日常工作流程。并且可以投资成本。

主要亮点

• 随着医疗保健领域不断变化的价值观和技术发展，对床旁 (POC) 检测的需求不断增长。有几个因素推动了对 POCT 的需求。例子包括传染病的增加、心脏病和糖尿病等生活方式疾病的增加、患者对家用 POC 设备的需求增加，以及创造更快、更易于使用的设备的技术进步。
• 在全球范围内，估计有 5.11 亿成年人患有糖尿病。到 2040 年，这个数字预计将上升到 5.7 亿以上。随着全球糖尿病患病率持续上升，还需要努力提高认识。预计亚太地区将有 37% 的糖尿病患者居住。此外，根据国际糖尿病联合会的数据，到 2021 年，全球将有 5.37 亿糖尿病患者。从 2021 年到 2045 年，全球糖尿病护理支出预计将从 9.66 亿美元增长到 10.53 亿美元。根据美国疾病控制和预防中心 (CDC) 最近的一份报告，超过 50% 被诊断为 COVID-19 的糖尿病患者住院。
• 通过即时检测 (POCT) 快速诊断临床症状可以改善患者预后。 POCT 发展背后的一个关键概念是通过使测试更接近患者并将结果快速方便地提供给医疗保健提供者来加速诊断和治疗。今天的 POCT 设备已经发生了变化，但获取记录合规性所需的数据仍然很耗时。强大的 POCT 管理系统和连接解决方案减少了手动输入结果所需的时间，消除了手动输入中固有的错误，并促进了实时访问结果，以确保医疗保健专业人员及时做出决策。让您做出决定。
• 此外，随着医疗保健数据分析越来越普遍地用于支持以患者为中心的护理和人口健康管理，以电子方式整合 POCT 结果以跟踪结果和纳入关键绩效指标变得至关重要。从 2015 年到 2019 年，美国的电子健康记录 (EHR) 支出将以 5.4% 的复合年增长率增长，到 2019 年将达到 145 亿美元。此外，根据日本看护协会的一项调查，从 2019 年 9 月到 2019 年 10 月，日本约有 63% 的医院已经引入了 EMR 系统。自 2000 年代初以来，政府一直在推广该系统的使用。
• COVID-19 的爆发给世界各地的医疗保健系统带来了巨大压力，因为他们正努力应对大量需要挽救生命的治疗的病人。一些国家正在寻找和准备关键的医疗设备，例如外科口罩、面罩、救生呼吸机或为患者提供的物理空间和床位。这些看似基本的必需品已成为高科技医疗设备领域的优先事项。

主要市场趋势

医院/重症监护中心有望占据很大的市场份额

• 医院越来越多地使用 POCT（即时检测）和电子病历系统，实时电子结果报告的重要性与日俱增。 POCT 数据管理系统不断发展以响应不断变化的市场需求以支持此类模型。从校园到校园，或从州/省到省以及跨医院，基于网络的连接数据管理平台释放了即时检测项目管理的关键效率。
• POC（Point of Care）技术最重要的方面是它的床边存在。 POC 技术促进并改善了患者与护士、医生和外科医生之间的互动，从而带来更好的医疗保健结果。床边血糖测试是 POC 市场中最普遍和最大的量。这些是第一批开发的设备，涉及数百台设备和数千名操作员。
• 此外，每个房间和治疗区域的壁挂式 POC 终端和带轮工作站都有可能为任何医院节省大量时间和金钱。各种研究得出的结论是，护士将 25-50% 的轮班时间用于在物理图表上以传统方式（铅笔和纸）完成文檔。换句话说，护士经常参与准确检索、创建、修改和存储关键患者数据。
• 此外，重症监护病房 (ICU)/重症监护病房的临床医生经常在密闭空间内收治重症患者，此时需要快速做出决定。因此，POCT 越来越多地被用作重症监护的常规组成部分，尤其是用于血气分析。血气分析仪（BGA）的主要目的是准确测量血气浓度（pH、pO2、pCO2等），但现代分析仪目前缺乏血红蛋白和电解质浓度（钠、钾、氯）、离子钙等.) 可以在相同的血液样本中进行测量。
• 西班牙一家医院正在与 NTT DATAzGroup 合作开发 SmartICU，在那里医生和技术人员与 NTT DATA 数据科学家合作，以实现更好的临床结果。在与医院合作开发 SmartICU 解决方案的为期一年的旅程开始时，该团队将数据管理和报告确定为主要障碍。
• 鑑于护士的非结构化手动每小时读数，关键单位的数据源远远超出高级仪器读数。每个团队都花费了一定的时间来发现和整合数据、设计和定制报告仪表板。有了这个基础，医院和 NTT DATA 团队决定专注于最具附加值的分析场景，并在此基础上进行分层。

预计北美将占据很大的市场份额

• 数十年来，北美地区一直使用即时检测 (POCT) 来诊断和监测急性和慢性疾病。用于诊断艾滋病、肺结核和疟疾等传染病的快速检测的可用性，主要是由于医生和患者能够通过智能手机将结果可视化并做出更好的临床决策。未来几年市场可能会发生变化。此外，即时诊断市场受到诊断行业最新创新的推动，这些创新为快速临床决策提供快速诊断，以支持治疗方案。
• 根据美国疾病控制和预防中心的数据，COPD 和哮喘等慢性下呼吸道疾病是美国第四大死因。每年有超过 160,000 人死亡。在美国，五分之一的 COPD 患者将在 30 天内重新入院。
• 政府采用 POC 是当务之急。 POC 测试减少了对医院资源的压力，还可以减少 ER 等待时间和就诊。生产中的大多数 POC 测试旨在检测传染病。例如，由美国国家生物医学成像研究所建立的 POC 技术研究网络正在加速 POC 诊断和检测产品的开发。诸如临床实验室改进法案 (CLIA) 指南等有利法规促进了 POC 测试优于其他形式。
• 目前，美国 POC 检测包括化学/电解质、妊娠、血红蛋白、心臟生物标誌物、血液学、粪便潜血、滥用药物、肝功能、血气和有限感染。由于现有的心臟生物标誌物 POC 测试存在缺陷，MEDITECH 的 Expanse Point of Care 软件、用于护士和治疗师与患者互动并提供最佳和最有效护理的最新网络移动技术已被引入 King's Daughters 医疗中心消灭传染病的目的。根据地理位置和潜在的传染病，POC 资源可以针对流行病、复杂的紧急情况或灾难进行定制。
• 随着医疗界努力寻找准确、及时的虚拟策略来改善患者护理，尤其是在 COVID-19 大流行期间，Evoke360 正在帮助提高护理质量和患者治疗效果。同时影响质量和风险调整后的分数，提高利润率并为供应商组织提供竞争优势。 2020 年 6 月，DataLink Software (DataLink) 指出了 Evoke360 及其提供者关係管理 (PRM) 模块的主要优势，使提供者能够从按服务收费转向基于价值的护理。 Evoke360 充当护理点解决方案，聚合来自不同来源的数据以加速抢先式患者护理，弥合护理差距以超越诊断。

竞争格局

医疗点 (POC) 数据管理软件市场是一个竞争激烈的市场，有多家公司进入该市场。市场适度分散，主要参与者似乎正在采取产品创新、併购等策略来扩大市场范围并保持竞争力。市场上的主要参与者包括 Siemens Healthineers AG、Abbott Point of Care Inc.、Danaher Corporation 等。

• 2022 年 1 月，格力泰与罗氏就胰岛素管理展开合作。数字健康合作伙伴关係将罗氏在医疗设备和 IT 解决方案方面的专业知识与 Glitech 的 FDA 批准的胰岛素剂量决策支持软件 GluCommander 相结合，以解决住院患者在医院床边血糖控制方面的挑战。旨在使护理点临床医生能够收集并立即对血糖控制数据采取行动，以改善患者安全和护理。
• 2022 年 2 月，数字健康公司 Butterfly Networks 与领先的基于云的医学图像管理套件的製造商 Intelerad 公司 Umbra Health 宣布建立合作伙伴关係，以加速和简化图像数据互操作性。该合作伙伴关係增强了 Butterfly Blueprint 企业平台的可扩展性，增加了医院和医疗保健系统之间有价值的超声信息的访问和共享。

其他好处

• Excel 格式的市场预测 (ME) 表
• 3 个月的分析师支持

内容

第1章介绍

• 研究假设和市场定义
• 调查范围

第2章研究方法

第 3 章执行摘要

第 4 章市场动态

• 市场概览
• 市场驱动力
  • 灵活连接和软件接口解决方案的创新
  • 增加医疗基础设施预算
  • 政府为推广 POC 测试所做的努力
• 市场挑战
  • 高昂的引入成本和运营挑战
• 市场机会
  • 快速检测和分散式医疗保健
• 波特五力分析
  • 供应商的议价能力
  • 买家的议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 竞争公司之间的敌对关係
• 当前监管状态（临床实验室改进法案 CLIA 指南和连接标准 (POCT1-A2)
• 床旁检测的新应用（败血症生物标誌物、内分泌检测、中风标誌物等）。

第 5 章 COVID-19 对市场的影响

第 6 章市场细分

• 按最终用户
  • 医院/重症监护中心
  • 诊断中心
  • 诊所/门诊
• 按应用
  • 传染病防治设备
  • 血糖监测
  • 血液凝固测量仪
  • 尿液分析
  • 循环代谢监测
  • 癌症标记
  • 血液学
  • 其他 POC 应用
• 地区信息
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 意大利
    • 法国
    • 其他欧洲地区
  • 亚太地区
    • 印度
    • 日本
    • 中国
    • 新加坡
    • 其他亚太地区
  • 拉丁美洲
  • 中东和非洲

第 7 章竞争格局

• 公司简介
  • Siemens Healthineers AG+（Conworx）
  • Abbott Point of Care Inc.+（Alere）
  • Danaher Company（HemoCue and Radiometer Medical ApS）
  • Roche Diagnostics Corporation
  • TELCOR Inc.
  • Orchard Software Corporation
  • Randox Laboratories Ltd
  • Thermo Fisher Scientific Inc.

第8章 投资分析

第9章 市场的将来性

The POC data management software market is expected to register a CAGR of 12.3% over the forecast period. Point-of-care technologies enable hospitals and clinics to invest more time and money in technologies that help accelerate the patient flow through practice and streamline doctors' and nurses' daily workflow by reducing waiting times.

Key Highlights

• The demand for point-of-care testing is growing in response to the value shift in healthcare and technological developments. Several factors are driving the need for POCT. Some of them include an increase in infectious diseases, a rise in lifestyle-related diseases, such as cardiac diseases and diabetes, a growing patient desire to use home-based POC devices, and technological advancements creating faster and easier-to-use devices.
• Around the globe, an estimated 511 million adults have diabetes. By 2040, this number is expected to rise to over 5,70 million. As diabetes worldwide continues to increase, so must the effort to raise awareness. 37% of all diabetic adults are expected to live in the Asia-Pacific region. Additionally, according to the International Diabetes Federation, the number of diabetic patients worldwide in 2021 was 537 million. Between 2021 - 2045, the global expenditures for diabetes treatment are anticipated to grow from USD 966 million to USD 1,053 million. According to a recent report by the Centers for Disease Control and Prevention (CDC), more than 50% of people with diabetes who have been diagnosed with COVID-19 are hospitalized.
• Rapid diagnosis of clinical conditions through point-of-care testing (POCT) can improve patient outcomes. The primary concept behind POCT growth is that bringing testing closer to the patient and results quickly and conveniently to the provider can speed up the diagnosis and treatment. Today's POCT devices are changing, but capturing the data required to document compliance is still time-consuming. A robust POCT management system and connectivity solution reduces the time spent manually typing in results, eliminates errors inherent to manually entered results, and facilitates real-time access to results so that providers can make timely decisions.
• Additionally, as healthcare data analytics are more commonly used to support patient-centered care and population health management, it is essential to have POCT results electronically integrated to include results tracking metrics and key performance indicators. Electronic medical records (EHR) expenditures in the United States grew at an annual average of 5.4% from 2015 to 2019, totaling USD 14.5 billion in 2019. Additionally, according to the Japanese Nursing Association survey, from September to October 2019, around 63% of the hospitals in Japan implemented the system of EMR. The government in the country has been promoting the system's use since the beginning of the 2000s.
• The COVID-19 outbreak placed a significant burden on healthcare systems worldwide that are straining to handle the volume of ill patients requiring life-saving treatment. Several countries have witnessed or are preparing for shortages of critical medical equipment such as surgical masks, face shields, life-saving ventilators, or even the physical space and beds for patients. These seemingly fundamental necessities become the priority in a world of increasingly high-tech healthcare equipment.

Key Market Trends

Hospitals/Critical Care Units Segment is Expected to Hold a Significant market Share

• The point-of-care testing (POCT) and electronic medical records system usage are rising in hospitals, where the importance of real-time electronic reporting of results is increasing. POCT data management systems are evolving to meet the marketplace's changing needs in supporting such a model. Across the hospitals, either from campus to campus or from one state/province to another, the web-based connectivity data management platform unlocks primary efficiency in point-of-care testing program management.
• The most critical aspect of POC (point-of-care) technology is its presence at the bedside. POC technologies facilitate and improve interactions between patients and their nurses, doctors, and surgeons, leading to better healthcare outcomes. Bedside glucose testing is the most widespread and occupies the most massive volume in the POC market. These were the first devices developed and involved hundreds of devices and thousands of operators.
• Further, a wall-mounted POC terminal in every room/treatment area or workstation on wheels has the potential to create significant time and cost savings in any hospital. Various studies concluded that nurses spend 25-50% of their shifts on documentation done in the traditional manner, which is on a physical chart with a pencil and paper. This means that nurses are regularly involved in accurate retrieval, production, modification, and critical patient data storage.
• Further, clinicians in intensive care units (ICU)/critical care units often work with critically ill patients in limited space and must make quick decisions at that point of care. Thus, critical care units have increasingly used POCT as a routine element of patient management, notably for blood gas analysis. The primary objective of the blood gas analyzer (BGA) is to deliver accurate measures of the blood gas levels (such as pH, pO2, and pCO2); however, modern analyzers can currently measure additional parameters in the same blood sample, such as the hemoglobin or electrolyte concentrations (includes sodium, potassium, chloride, and ionized calcium).
• The development of SmartICU at a hospital in Spain, in partnership with NTT DATA (an NTT DATAzGroup), is teaming its doctors and technologists with NTT DATA's data scientists to get better clinical results. At the outset of a one-year journey of developing the SmartICU solution with the hospital, the team identified data management and reporting as the primary obstacle.
• Data sources at the critical units go far beyond high-level device readings when one considers them unstructured, such as the nurse's hourly measurements manually. The teams spent a certain amount of time on data discovery, integration, reporting dashboard designing, and customizing. With this foundation, the hospital and NTT DATA teams have focused on the most value-adding analytic scenarios to layer on top.

North America is Expected to Hold a Significant Market Share

• Point-of-care testing (POCT) has been used in the North American region for several decades to diagnose and monitor acute and chronic medical conditions. The growing availability of rapid tests for diagnosing infectious diseases, such as HIV, TB, or malaria, that primarily enable physicians and patients to visualize the results from a smartphone and make appropriate clinical decisions may transform the market over the next few years. The point-of-care diagnostics market is also driven by the latest innovations in the diagnostics industry to provide an expedited diagnosis for quick clinical decision-making to support treatment regimens.
• According to the Centers for Disease Control and Prevention, chronic lower respiratory diseases, including COPD and asthma, are the fourth-leading causes of mortality in the United States. They are responsible for more than 160,000 deaths a year. It is expected that 1 in 5 COPD patients will be readmitted within 30 days in the United States.
• There is a preference for POC adoption by governments. POC testing reduces the strain on hospital resources, as well as ER wait times and visits. The majority of POC tests produced are designed for detecting infectious diseases. For instance, the Point of Care Technologies Research Network established by the United States National Institute of Biomedical Imaging and Bioengineering accelerates POC diagnostics or testing product development. Favorable regulations, such as the Clinical Laboratory Improvement Amendments (CLIA) guidelines, promote POC testing over other forms.
• Presently, US POC testing caches comprise chemistry/electrolytes, pregnancy, hemoglobin, cardiac biomarkers, hematology, fecal occult blood, drugs of abuse, liver function, blood gases, and limited infectious diseases. Owing to the deficiencies with existing POC tests for cardiac biomarkers, MEDITECH's Expanse Point of Care software, the company's latest web-based mobile technology for nurses and therapists to provide the best and most efficient patient-facing care, has been implemented at King's Daughters Medical Center, aiming to eliminate infectious diseases. Depending on geographic location and potential infectious diseases, POC resources can be customized for pandemics, complex emergencies, or disasters.
• As the healthcare community scrambles for accurate, timely, and virtual strategies to improve patient care, especially amid the COVID -19 pandemic, Evoke360 not only enhances the quality of care and patient outcomes but also impacts quality and risk adjustment scores that increase profit margins and give provider organizations a competitive edge. In June 2020, DataLink Software (DataLink) pointed to the key advantages of Evoke360 and its Provider Relations Management (PRM) module, enabling providers to transition from fee-for-service to value-based care. Evoke360 serves as a point-of-care solution, aggregating data from disparate sources to accelerate preemptive patient care, closing gaps in care to treat more than the diagnosis results.

Competitive Landscape

The Point-of-Care Data Management Software Market is highly competitive, owing to the presence of multiple players in the market. The market appears to be moderately fragmented, with the key players adopting strategies such as product innovation, mergers, and acquisitions, to expand their reach and stay competitive in the market. Some of the market's major players are Siemens Healthineers AG, Abbott Point of Care Inc., and Danaher Corporation, among others.

• In January 2022, Glytec and Roche struck a partnership on insulin management. This digital health collaboration combines Roche's expertise in medical devices and IT solutions with Glytec's FDA-cleared insulin dosing decision support software, Glucommander, to address the challenges with inpatient blood sugar management at the hospital bedside, designed to improve patient safety and care by empowering point-of-care clinicians to collect and take immediate action on glycaemic management data.
• In February 2022, Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ultrasound, and Ambra Health, an Intelerad Company and maker of a leading cloud-based medical image management suite, announced a partnership to accelerate and simplify interoperability for bedside imaging data. This partnership strengthens Butterfly Blueprint's enterprise platform's scalability and will enhance access and shareability of valuable ultrasound information across hospitals and health systems.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Innovation in Flexible Connectivity and Software Interface Solutions
  • 4.2.2 Rise in Healthcare Infrastructure Budgets
  • 4.2.3 Government Initiatives for Promoting the Deployment of POC Testing
• 4.3 Market Challenges
  • 4.3.1 High Deployment Costs and Operational Challenges
• 4.4 Market Opportunities
  • 4.4.1 Rapid Testing and Decentralized Healthcare
• 4.5 Porters Five Force Analysis
  • 4.5.1 Bargaining Power of Suppliers
  • 4.5.2 Bargaining Power of Buyers
  • 4.5.3 Threat of New Entrants
  • 4.5.4 Threat of Substitutes
  • 4.5.5 Intensity of Competitive Rivalry
• 4.6 Current Regulatory Landscape (Guidelines of Clinical Laboratory Improvement Amendments CLIA) and Connectivity Standards (POCT1-A2))
• 4.7 Emerging Applications in Point-of-Care Testing (Sepsis Biomarkers, Endocrine Testing, Stroke Markers, etc.)

5 IMPACT OF COVID-19 ON THE MARKET

6 MARKET SEGMENTATION

• 6.1 By End User
  • 6.1.1 Hospitals/Critical Care Units
  • 6.1.2 Diagnostic Centers
  • 6.1.3 Clinics/Outpatient
• 6.2 By Application
  • 6.2.1 Infectious Disease Devices
  • 6.2.2 Glucose Monitoring
  • 6.2.3 Coagulation Monitoring
  • 6.2.4 Urinalysis
  • 6.2.5 Cardiometabolic Monitoring
  • 6.2.6 Cancer Markers
  • 6.2.7 Hematology
  • 6.2.8 Other POC Applications
• 6.3 By Geography
  • 6.3.1 North America
    • 6.3.1.1 United States
    • 6.3.1.2 Canada
  • 6.3.2 Europe
    • 6.3.2.1 Germany
    • 6.3.2.2 United Kingdom
    • 6.3.2.3 Italy
    • 6.3.2.4 France
    • 6.3.2.5 Rest of Europe
  • 6.3.3 Asia-Pacific
    • 6.3.3.1 India
    • 6.3.3.2 Japan
    • 6.3.3.3 China
    • 6.3.3.4 Singapore
    • 6.3.3.5 Rest of Asia-Pacific
  • 6.3.4 Latin America
  • 6.3.5 Middle East & Africa

7 COMPETITIVE LANDSCAPE

• 7.1 Company Profiles
  • 7.1.1 Siemens Healthineers AG + (Conworx)
  • 7.1.2 Abbott Point of Care Inc. + (Alere)
  • 7.1.3 Danaher Company (HemoCue and Radiometer Medical ApS)
  • 7.1.4 Roche Diagnostics Corporation
  • 7.1.5 TELCOR Inc.
  • 7.1.6 Orchard Software Corporation
  • 7.1.7 Randox Laboratories Ltd
  • 7.1.8 Thermo Fisher Scientific Inc.

8 INVESTMENT ANALYSIS

9 FUTURE OF THE MARKET